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Glucose-6-phosphate dehydrogenase (G6PD) deficiency
tests play a critical role in supporting the safe treatment
and elimination of malaria. Evaluating G6PD activity in
those infected with Plasmodium vivax will be essential in
order to treat and achieve radical cures. Our goal is to
establish a unique specimen repository with cryopreserved
specimens highly characterized for G6PD activity. Provid-
ing such specimens to designers of G6PD point-of-care
tests, will support both the development and evaluation of
new diagnostic devices. Because G6PD-deficiency preva-
lence ranges from <1–>15%, obtaining fresh blood speci-
mens with a range of levels of G6PD activity - as well as
specimens from heterozygous females - typically requires
constant screening from large numbers of subjects. Thus,
developers would highly benefit by using the same panel
of specimens from the repository over the entire course of
the development of a specific G6PD test. Currently the
repository constitutes specimens from adults of known
G6PD-deficient population groups and will be expanded
over time with diverse ethnic backgrounds. Standard
operation procedures and formulations have been opti-
mized to allow cryopreservation of red blood cells (RBC)
and stabilize G6PD enzyme activity within the RBC. Flow
cytometry and kinetic assays demonstrate that specimens
can be stored a minimum of six months under these opti-
mized conditions. Critically, thawed specimens demon-
strate stability for seven days. We are using Freezerworks
database to maintain the chain of custody of all specimens.
Cytochemical staining is performed to pedigree the speci-
mens. The specimens are processed and tested for G6PD
activity immediately by quantitative and qualitative assays.
Samples are stored depending on the phenotype in order
to increase the capacity of G6PD diverse specimens.
Samples with normal G6PD activity are more prevalent
and discarded to accommodate intermediate and deficient
specimens. Once samples have been tested and selected
for the repository, three preservation methods are used:
(1) whole RBCs are cryopreserved in glycerolyte and
stored in liquid nitrogen for G6PD phenotyping, (2) whole
RBCs without glycerolyte are preserved in liquid nitrogen
for phenotyping, and (3) peripheral mononuclear blood
cells are preserved for DNA sequencing and genotyping.
The G6PD specimen repository at PATH will provide a
low-cost service to research, commercial, and other orga-
nizations with compatible product development goals that
benefit the global health community.
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